Dear Doctor Letter (Rote-Hand-Brief) on Vistide® (cidofovir): Serious adverse reactions following off-label use
2011.01.13
Active substance: cidofovir
Call for reporting of all suspected cases of adverse drug reactions in association with the use of Vistide®.
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN